Today, Kimiagaran Chemical Industries Company, as a leading company in the production of ethoxylated products in the Middle East region, started its activity in 1374 after years of continuous efforts, continuous research and huge private sector investment with the production of various pharmaceutical polyethylene glycols.

And in the next steps, he proceeded to produce and supply various types of pharmaceutical and chemical ethoxylated products, including polysorbates, ethoxylated nonylphenols, ethoxylated fatty alcohols, ethoxylated fatty amines, ethoxylated castor oil, ethoxylated fatty acids and ethylene glycols. In recent years, this company, in line with efforts for the country's self-sufficiency and foreign exchange savings, for the first time in the Middle East region, succeeded in producing pharmaceutical and chemical-based monopropylene glycol. It means metronidazole and metronidazole benzoate.

And currently, it has the active ingredients of acetaminophen and aspirin in its product portfolio. And following this proud action, Iran's name was included in the list of 4 metronidazole producing countries in the world. In June 2019, in line with the goals of the large-scale development of the company in the pharmaceutical industry, the largest pharmaceutical raw material settlement in the Middle East was established in this complex 16 hectares, with the start of work, the unit for the production of acetaminophen pharmaceutical raw material was opened. Currently, various production units, including the active ingredients of mefenamic acid, metformin, and the basic ingredient of para-aminophenol (PAP), are being built in this town.